CYP2B6

cytochrome P450 family 2 subfamily B member 6

Pharmacogene

Summary

This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Known Variants88 total

rsidPosition (GRCh37)AllelesClassClinVar
rs3488343219:40,991,367A/Tmissense variantlikely benign
rs3397333719:40,991,381A/Tmissense variant—
rs3398038519:40,991,388A/Gmissense variant—
rs3392610419:40,991,390C/Amissense variant—
rs3428477619:40,991,391G/Cmissense variant—
rs3606084719:41,004,125G/Amissense variant—
rs3577304019:41,004,381G/Amissense variantlikely benign
rs14588440219:41,004,406G/Tmissense variant—
rs382671119:41,006,919C/Gmissense variant—
rs3605653919:41,006,923C/Tmissense variant—
rs4548260219:41,009,350C/Amissense variantlikely benign
rs13902962519:41,010,006G/Cmissense variant—
rs3469875719:41,010,088C/Gmissense variant—
rs19392291719:41,010,108C/Amissense variant—
rs3482650319:41,012,339C/Tmissense variant—
rs3597956619:41,012,693T/Amissense variant—
rs19392291819:41,012,740G/Amissense variant—
rs3501009819:41,012,803C/Amissense variant—
rs321136919:41,016,726A/Gmissense variant—
rs56408398919:41,016,778G/Amissense variant—
rs480210119:41,496,461T/Cupstream gene variant—
rs3422310419:41,497,129T/Cupstream gene variant—
rs3447744519:41,497,256T/C—likely benign
rs15074242319:41,497,264C/A—likely benign
rs819270919:41,497,274C/Amissense variant—
rs77150158219:41,497,340C/G—uncertain significance
rs3530348419:41,497,346A/Gmissense variant—
rs1040395519:41,509,438T/Gintron variant—
rs28186490719:41,509,920T/Astop gaineddrug response
rs19970487219:41,509,936G/A—uncertain significance
rs37229536019:41,510,027G/A—uncertain significance
rs14800990619:41,510,038G/T—uncertain significance
rs143560187619:41,510,047G/C—uncertain significance
rs18633545319:41,510,063G/Tmissense variantdrug response
rs78009823019:41,510,066A/G—uncertain significance
rs13980127619:41,510,208T/Cmissense variantdrug response
rs1272165519:41,510,282A/Gmissense variantlikely benign
rs77048345519:41,510,312G/A—uncertain significance
rs77547313719:41,510,328T/C—uncertain significance
rs18304077819:41,510,339C/T—uncertain significance
rs138177382819:41,510,350G/T—uncertain significance
rs480341919:41,512,792C/Tintron variant—
rs37381917119:41,512,815C/T—uncertain significance
rs374527419:41,512,841G/Tmissensedrug response
rs14058229019:41,512,848A/G—uncertain significance
rs37348963719:41,512,873T/Gmissense variantdrug response
rs3607918619:41,512,918T/Cmissense variantdrug response
rs55816310019:41,512,944T/C—uncertain significance
rs37142491019:41,512,962T/Cmissense variantdrug response
rs1272164619:41,515,107C/Tintron variant—
rs37635913419:41,515,192G/A—likely benign
rs3534998719:41,515,201C/A—likely benign
rs227934319:41,515,263A/Gmissensebenign
rs251618655319:41,515,267C/A—uncertain significance
rs18997062319:41,515,273C/T—likely benign
rs77349486719:41,515,275A/T—uncertain significance
rs227934419:41,515,483G/Aintron variant—
rs227934519:41,515,702T/G——
rs2839949919:41,515,810T/Cmissensedrug response
rs131597102919:41,515,957C/T—uncertain significance
rs37025150719:41,518,223G/A—uncertain significance
rs75811090119:41,518,235G/A—uncertain significance
rs56721932619:41,518,245G/A—uncertain significance
rs55365883119:41,518,260A/G—uncertain significance
rs56598064119:41,518,266G/C—uncertain significance
rs251619187819:41,518,281A/G—uncertain significance
rs37502090919:41,518,319G/A—uncertain significance
rs3409709319:41,518,370C/Tstop gaineddrug response
rs20045861419:41,518,371G/A—uncertain significance
rs20033443719:41,518,399G/A—likely benign
rs3544927119:41,518,573C/T—likely benign
rs196930423519:41,518,585G/A—uncertain significance
rs214467723319:41,518,642G/A—uncertain significance
rs3566188019:41,518,644C/T—likely benign
rs124827145719:41,518,677T/A—uncertain significance
rs86712667619:41,518,678G/T—uncertain significance
rs819271919:41,518,773C/A——
rs480210419:41,521,527A/T——
rs726032919:41,521,638G/T——
rs810984819:41,522,069G/A——
rs75878914519:41,522,575G/T—uncertain significance
rs14348841719:41,522,579C/T—likely benign
rs14695637019:41,522,591A/G—likely benign
rs36853140219:41,522,642C/T—likely benign
rs14741057819:41,522,670C/T—uncertain significance
rs321137119:41,522,715C/Tmissense—
rs14852055419:41,522,728G/A—uncertain significance
rs104238919:41,524,153T/C3 prime UTR variant—

Gene information from NCBI Gene. Variant classifications from ClinVar.